Data highlight progress toward personalized stem cell therapy for Parkinson's disease
Interim clinical findings from the first Phase I/IIa trial using autologous-induced pluripotent stem cell (iPSC)-derived dopamine neuron precursor cells, along with the novel quality-control tools developed to manufacture ...
Jul 9, 2026
0
4







